Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark J Walker

Showing results (181-190 of 199) with videos related to

Pageof 20
Sort By:
Antibiotics (Basel, Switzerland)|April 23, 2022
Neurodegenerative Disease Treatment Drug PBT2 Breaks Intrinsic Polymyxin Resistance in Gram-Positive BacteriaDavid M P De Oliveira, Bernhard Keller, Andrew J Hayes, et al.
Science Advances|June 5, 2020
All major cholesterol-dependent cytolysins use glycans as cellular receptorsLucy K Shewell, Christopher J Day, Freda E-C Jen, et al.
Nature Communications|July 1, 2025
An mRNA vaccine encoding five conserved Group A Streptococcus antigensNichaela Harbison-Price, Ismail Sebina, Rhiannon A Bolton, et al.
Mbio|December 13, 2018
Chemical Synergy between Ionophore PBT2 and Zinc Reverses Antibiotic ResistanceLisa Bohlmann, David M P De Oliveira, Ibrahim M El-Deeb, et al.
Mbio|January 11, 2022
Rescuing Tetracycline Class Antibiotics for the Treatment of Multidrug-Resistant Acinetobacter baumannii Pulmonary InfectionDavid M P De Oliveira, Brian M Forde, Minh-Duy Phan, et al.
Cell Host & Microbe|June 13, 2014
The classical lancefield antigen of group a Streptococcus is a virulence determinant with implications for vaccine designNina M van Sorge, Jason N Cole, Kirsten Kuipers, et al.
Nature Microbiology|April 23, 2026
Emergence of distinct Streptococcus pyogenes emm1 and emm12 lineages in ChinaYuanhai You, Dingle Yu, Chao Yang, et al.
Nature Communications|August 5, 2014
Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracyclineViolette Da Cunha, Mark R Davies, Pierre-Emmanuel Douarre, et al.
The Lancet. Microbe|May 11, 2022
A controlled human infection model of Streptococcus pyogenes pharyngitis (CHIVAS-M75): an observational, dose-finding studyJoshua Osowicki, Kristy I Azzopardi, Loraine Fabri, et al.
Nature Communications|January 29, 2015
Corrigendum: Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracyclineViolette Da Cunha, Mark R Davies, Pierre-Emmanuel Douarre, et al.
Pageof 20

Showing results (181-190 of 199) with videos related to

Sort By:
Pageof 20
Antibiotics (Basel, Switzerland)|April 23, 2022
Neurodegenerative Disease Treatment Drug PBT2 Breaks Intrinsic Polymyxin Resistance in Gram-Positive BacteriaDavid M P De Oliveira, Bernhard Keller, Andrew J Hayes, et al.
Science Advances|June 5, 2020
All major cholesterol-dependent cytolysins use glycans as cellular receptorsLucy K Shewell, Christopher J Day, Freda E-C Jen, et al.
Nature Communications|July 1, 2025
An mRNA vaccine encoding five conserved Group A Streptococcus antigensNichaela Harbison-Price, Ismail Sebina, Rhiannon A Bolton, et al.
Mbio|December 13, 2018
Chemical Synergy between Ionophore PBT2 and Zinc Reverses Antibiotic ResistanceLisa Bohlmann, David M P De Oliveira, Ibrahim M El-Deeb, et al.
Mbio|January 11, 2022
Rescuing Tetracycline Class Antibiotics for the Treatment of Multidrug-Resistant Acinetobacter baumannii Pulmonary InfectionDavid M P De Oliveira, Brian M Forde, Minh-Duy Phan, et al.
Cell Host & Microbe|June 13, 2014
The classical lancefield antigen of group a Streptococcus is a virulence determinant with implications for vaccine designNina M van Sorge, Jason N Cole, Kirsten Kuipers, et al.
Nature Microbiology|April 23, 2026
Emergence of distinct Streptococcus pyogenes emm1 and emm12 lineages in ChinaYuanhai You, Dingle Yu, Chao Yang, et al.
Nature Communications|August 5, 2014
Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracyclineViolette Da Cunha, Mark R Davies, Pierre-Emmanuel Douarre, et al.
The Lancet. Microbe|May 11, 2022
A controlled human infection model of Streptococcus pyogenes pharyngitis (CHIVAS-M75): an observational, dose-finding studyJoshua Osowicki, Kristy I Azzopardi, Loraine Fabri, et al.
Nature Communications|January 29, 2015
Corrigendum: Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracyclineViolette Da Cunha, Mark R Davies, Pierre-Emmanuel Douarre, et al.
Pageof 20